检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]中国医科大学附属第四医院肿瘤内科,辽宁沈阳110032
出 处:《中华肿瘤防治杂志》2011年第20期1620-1623,共4页Chinese Journal of Cancer Prevention and Treatment
摘 要:目的:运用系统评价Meta分析的方法评价香菇多糖(LNT)单药或联合其他药物治疗恶性胸腔积液(MPE)的临床疗效及安全性。方法:应用Pubmed、Cochrane图书馆、Embase、CBM、CNKI、维普及万方数据库系统,全面收集有关LNT单药或联合其他药物治疗MPE的临床对照研究。结果:本系统评价共纳入17篇随机对照试验,共计978例患者,其中LNT组500例,顺铂组478例。Meta分析结果显示,LNT组临床有效率明显优于顺铂组(OR=3.68,95%CI=2.75~4.94;P<0.000 01);LNT组治疗后Karnofsky评分升高患者例数均显著多于顺铂组患者(OR=3.79,95%CI=2.46~5.84,P<0.000 01),其降低及稳定患者例数明显低于顺铂组患者(OR=0.41,95%CI=0.21~0.78,P=0.007;OR=0.37,95%CI=0.22~0.60,P<0.000 1);LNT组胃肠道反应和血液学毒性发生率较顺铂组明显减少(OR=0.31,95%CI=0.21~0.47,P<0.000 01;OR=0.49,95%CI=0.28~0.84,P=0.01)。结论:现有证据表明,LNT单药或联合其他药物治疗MEP的临床疗效及安全性均优于顺铂单药,可广泛应用于临床治疗晚期肿瘤恶性胸腔积液。OBJECTIVE: To investigate the efficacy and safety of lentinan (LNT) for the treatment of malignant pleural effusion (MPE) by conducting a meta-analysis. METHODS: Publications addressing the efficacy and safety of LNT for the treatment of MPE were selected from Pubmed, Cochrane library, Embase, CBM, CNKI, VIP and Wanfang databases. RESULTS: Seventeen studies involving 978 patients were identified, with 500 patients in LNT group and 478 patients in cisplatin group. Patients in LNT group has a better clinical response rate than those in cisplatin group (OR = 3.68, 95%CI 2.75-4.94; P〈0.000 01); There was sig nificant difference between LNT group and cisplatin group on rising ratio of Karnofsky scores (OR = 3. 79, 95% CI 2.46 5.84, P〈0. 000 01). Meanwhile, decreasing and stable ratio also had an obviously significant difference between LNT group and eisplatin group (OR=0.41, 95%CI=0.21 0.78, P=0.007; OR=0.37; 95%CI=0.22 0.60, P〈 0. 000 1). In addition, LNT group had lower incidence of gastrointestinal reactions and hematological toxicity (OR 0.31, 95%CI=0. 21 0. 47, P〈0. 000 01; OR=0. 49, 95%CI=0. 28-0. 84, P=0.01). CONCLUSION: Evidences show that lentinan single and combination regimen has a better clinical efficacy and safety.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222